NCT03786081 2026-03-13Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical CancerSeagen Inc.Phase 1/2 Active not recruiting214 enrolled
NCT04982237 2025-11-19A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical CancerAkesoPhase 3 Active not recruiting445 enrolled